Cabaletta Bio Inc (NAS:CABA)
$ 3.035 (0%) Market Cap: 494.87 Mil Enterprise Value: 404.69 Mil PE Ratio: 0 PB Ratio: 3.26 GF Score: 34/100

Cabaletta Bio Inc at TD Cowen Healthcare Conference Transcript

Mar 3, 2026 / 04:10 PM GMT
Release Date Price: $3.25 (-1.52%)


Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

CABA.OQ - Cabaletta Bio Inc
Cabaletta Bio Inc at TD Cowen Healthcare Conference
Mar 03, 2026 / 04:10PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Good morning and welcome once again to TD Cowan's tech analyst here at Cowan. It's my pleasure to moderate a fireside chat with Kabaleta. We have with us today, Steven Nickberger, the co-founder, President and CEO David Chang, CMO, and Steve Gael, CEO. So guys, I'll kick it to you for a brief state of the company, biggest strengths, biggest challenges, and what is Caval going to do to create shareholder value over the next year.

--------------------------------------------------------------------------------
Unidentified_2 [2]
--------------------------------------------------------------------------------
Thanks. Thanks for having us. Thanks for investing a few minutes with us.

So we're in a
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot